Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023728038> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W2023728038 endingPage "S28" @default.
- W2023728038 startingPage "S28" @default.
- W2023728038 abstract "Primary Sjögren's syndrome (pSS) is a chronic autoimmune systemic disease, characterized by a lymphoplasmocytic infiltration and a progressive destruction of salivary and lachrymal glands, leading to ocular and mouth dryness. T cells were originally considered to play the initiating role in the autoimmune process, while B cells were restricted to autoantibody production. However, recent years have seen growing evidence that the roles of B cells in pSS pathophysiology are multiple, and that these cells may actually play a central role in the development of the disease. B cells are over-stimulated and produce excessive amounts of immunoglobulins and various autoantibodies. Peripheral blood and salivary-gland B-cell subset distribution is altered, leading to the constitution of ectopic germinal centers where auto-reactive clones may escape tolerance checkpoints. B cells control T-cell activation by different means: B effector cells guide Th1 or Th2 differentiation, whereas regulatory B cells inhibit T-cell proliferation. Several B-cell specific cytokines, such as BAFF or Flt-3L, are instrumental in the occurrence of B-cell dysfunction. Chronic and excessive stimulation of B cells may lead to the development of lymphoma in pSS patients. Autoantibodies and blood B-cell subset analysis are major contributors of a clinical diagnosis of pSS. These considerations led to the development of B-cell depletion therapies for the management of pSS. Rituximab, a monoclonal antibody to CD20, is the best studied biologics in pSS, but other treatments hold promise, targeting for example CD22 or BAFF. Thus, during the last 20 years, the understanding of the multifaceted roles of B cells in pSS has revolutionized the management of this complex disease." @default.
- W2023728038 created "2016-06-24" @default.
- W2023728038 creator A5018138289 @default.
- W2023728038 creator A5068576627 @default.
- W2023728038 creator A5081166792 @default.
- W2023728038 date "2008-01-01" @default.
- W2023728038 modified "2023-09-26" @default.
- W2023728038 title "OR.67. Selective Silencing of Disease-associated Auto-reactive B Lymphocytes by a Chimeric Antibody Targeting Their Inhibitory Fc-gammaIIB and CD22 Receptors" @default.
- W2023728038 doi "https://doi.org/10.1016/j.clim.2008.03.463" @default.
- W2023728038 hasPublicationYear "2008" @default.
- W2023728038 type Work @default.
- W2023728038 sameAs 2023728038 @default.
- W2023728038 citedByCount "0" @default.
- W2023728038 crossrefType "journal-article" @default.
- W2023728038 hasAuthorship W2023728038A5018138289 @default.
- W2023728038 hasAuthorship W2023728038A5068576627 @default.
- W2023728038 hasAuthorship W2023728038A5081166792 @default.
- W2023728038 hasConcept C159654299 @default.
- W2023728038 hasConcept C163764329 @default.
- W2023728038 hasConcept C170286685 @default.
- W2023728038 hasConcept C203014093 @default.
- W2023728038 hasConcept C2778453870 @default.
- W2023728038 hasConcept C2778957590 @default.
- W2023728038 hasConcept C2780653079 @default.
- W2023728038 hasConcept C71924100 @default.
- W2023728038 hasConcept C86803240 @default.
- W2023728038 hasConcept C96926380 @default.
- W2023728038 hasConceptScore W2023728038C159654299 @default.
- W2023728038 hasConceptScore W2023728038C163764329 @default.
- W2023728038 hasConceptScore W2023728038C170286685 @default.
- W2023728038 hasConceptScore W2023728038C203014093 @default.
- W2023728038 hasConceptScore W2023728038C2778453870 @default.
- W2023728038 hasConceptScore W2023728038C2778957590 @default.
- W2023728038 hasConceptScore W2023728038C2780653079 @default.
- W2023728038 hasConceptScore W2023728038C71924100 @default.
- W2023728038 hasConceptScore W2023728038C86803240 @default.
- W2023728038 hasConceptScore W2023728038C96926380 @default.
- W2023728038 hasLocation W20237280381 @default.
- W2023728038 hasOpenAccess W2023728038 @default.
- W2023728038 hasPrimaryLocation W20237280381 @default.
- W2023728038 hasRelatedWork W1967524335 @default.
- W2023728038 hasRelatedWork W1991423662 @default.
- W2023728038 hasRelatedWork W2010282370 @default.
- W2023728038 hasRelatedWork W2027638367 @default.
- W2023728038 hasRelatedWork W2145073108 @default.
- W2023728038 hasRelatedWork W2148749566 @default.
- W2023728038 hasRelatedWork W2155087150 @default.
- W2023728038 hasRelatedWork W2322842969 @default.
- W2023728038 hasRelatedWork W2518196601 @default.
- W2023728038 hasRelatedWork W4288050659 @default.
- W2023728038 hasVolume "127" @default.
- W2023728038 isParatext "false" @default.
- W2023728038 isRetracted "false" @default.
- W2023728038 magId "2023728038" @default.
- W2023728038 workType "article" @default.